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Background: Mental health comorbidities are frequent in patients with vertigo and
dizziness. The current study was conducted in a specialized interdisciplinary university
center for vertigo and dizziness. Clinical routines consist of a structured work-up in which
neuro-otological and neurological tests are performed to first detect possible organic
vestibular deficits. In addition, psychiatric disorders and comorbidities are considered.
The study aimed to evaluate neurologists’ awareness of psychiatric next to somatic
disorders within patients’ first examination in terms of diagnostic congruence between
neurologists’ diagnoses and structured clinical assessment of mental disorders.
Methods: The study involved 392 patients. Diagnostic evaluation included (a) structured
history-taking (including psychosocial anamnesis), neurological, and neuro-otological
diagnostics conducted by neurologists and (b) a structured clinical interview for mental
disorders (SCID-I) conducted by psychologists and final-year medical or psychology
students. Cohen’s Kappa was calculated to determine agreement rates regarding
depression and anxiety disorders; additionally, sensitivity and specificity were evaluated.
Results: Neurologists’ assessments led to at least one psychiatric diagnosis among the
main diagnoses in 40 (10.2 %) patients, whereas the structured clinical interview led to at
least one DSM-IV psychiatric diagnosis in 174 (44.4%) of the patients. Agreement was
low (κ < 0.2); sensitivity was low (15%) but specificity was high (98%).
Conclusions: Agreement between the diagnosis of neurologists and structured clinical
interviews for psychiatric disorders is low. Since psychiatric disorders are frequent in
vertigo and dizziness and tend to take a chronic course, improving early recognition and
implementing appropriate care concepts is vital.
Keywords: structured clinical interviews for mental disorders, vertigo, dizziness, psychiatric disorders, diagnostic
agreement
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INTRODUCTION
Vertigo and dizziness are frequently presented symptoms that are
comorbid with mental disorders in about 30–50% of complex
and often chronic vertigo and dizziness syndromes (1, 2). The
most common comorbidities are depression and anxiety (3).
Additionally, functional vertigo and dizziness symptoms (i.e.,
symptoms without any underlying structural dysfunction) are
very common and often occur due to a psychiatric condition
(4, 5). Initially, patients with vertigo and dizziness symptoms
usually consult their general practitioner or a specialist from a
somatic discipline, typically a neurologist or otolaryngologist.
Since mental comorbidities often tend to take a chronic course
if not recognized early (6, 7), detecting possible mental disorders
early in the diagnostic process would be beneficial in order
to initiate the appropriate treatment or prevention methods.
However, even though mental comorbidities are frequent in
many neurological disorders and are thought to complicate
treatment (8), few investigations toward neurologists’ awareness
of psychiatric conditions in clinical routine exist. One study
examining this issue found low sensitivity in neurologists’
detection of depression in patients with Parkinson’s symptoms
(9). Findings from respective studies in other medical fields, e.g.,
in oncology (10), primary and secondary care regarding alcohol
problems (11), and other somatic hospital departments (12) agree
that the recognition and correct identification of psychiatric
conditions or psychological distress is low across the disciplines.
Therefore, collaborative care approaches that aim at integrating
psychosomatic or psychiatric assessments and care into somatic
care are becoming increasingly popular since they could assist in
recognition and treatment of mental health conditions (13, 14).
The aim of the current study was to investigate neurologists’
recognition of psychiatric diagnoses in patients with vertigo
and dizziness symptoms during clinical routine, i.e., a first
examination at a specialized tertiary care center. To do so, we
aimed to evaluate the prevalence rates estimated by the primary
diagnoses of neurologists and compare them with those detected
by the current gold standard, the structured clinical interview
for mental disorders after DSM-IV, SCID-I (15). In this regard,
we aimed at specifically evaluating the concordance of anxiety
and depressive disorder diagnoses since these are most common
(3, 16).
METHODS
Study Design, Setting, and Sample
This secondary cross-sectional analysis of a longitudinal study
was conducted between May 2010 and June 2012 and involved
687 patients who gave their informed consent (from a total of 860
eligible patients). Patients were recruited through routine care
appointments at the interdisciplinary German Center for Vertigo
and Balance Disorders, University Hospital Munich, Germany.
Due to organizational reasons (e.g., living outside of Munich
or nausea and vomiting after caloric testing), not all patients
finished the time consuming psychological assessment following
the neurological and neuro-otological procedures. Therefore, we
were able to include and analyse complete data from 392 patients
(44.1% male, 54.8 ± 16.0 years of age). The majority of these
patients, i.e., almost 80 % presented with chronic complaints that
had persisted for at least 6 months before initial presentation at
the center (17).
Patients were included if they were at least 18 years of
age and were fluent with the German language. Furthermore,
assessment via SCID-I and completed relevant questionnaires
needed to be available. Exclusion criteria were any of the
following diagnoses: neurodegenerative disorder (e.g., dementia),
schizoaffective disorder, psychotic disorder, substance abuse, or
severe suicidal tendencies. All participants were informed about
the aims of the study and provided written informed consent. The
study was approved by the Ethics Committee of the University
of Munich (ref: 108–10). The design of this study has been
previously described in detail by Lahmann et al. (18).
Neurological Diagnostic Work-Up
All patients underwent structured history taking and a systematic
and standardized physical examination by neurologists at
the German Center for Vertigo and Balance Disorders,
including complete neurological, neuro-otological, neuro-
ophthalmological, and neuro-orthoptic examination. Details
on the neurological assessments are provided elsewhere (17).
History taking included a psychosocial anamnesis to evaluate
mental health comorbidity in an unstructured manner. However,
neurologists were not explicitly instructed to screen for
psychiatric disorders since the first neuro-otological examination
aims at disclosing vestibular dysfunctions. Psychiatric diagnoses
were assessed according to the International Classification
of Diseases [ICD-10; (19)]. All diagnoses, i.e., main and
secondary diagnoses, were noted in a specified section within
the patients’ reports; these were extracted for the current study.
However, some physicians noted aspects of psychopathology
(i.e., depressed mood, thought disorders, etc.) in the running
text of the patient’s report which were not coded in the diagnoses
section.
Neurologists working at the center are residents in their
second or higher year of specialized medical training. The
residents are supervised by a senior neurologist specialized in
neuro-otology with whom every diagnostic decision is discussed.
At the time of data collection, there were seven residents and
five senior neurologists working at the center. The neurologists
are clinically trained in the screening of mental disorders via
standardized clinical teachings and courses within the field of
psychosomatic medicine, which are held by colleagues from the
psychosomatic department.
Psychometric Examination: Structured
Clinical Interview (SCID-I)
Psychologists and final-year medical or psychology students
conducted structured clinical interviews (SCID-I) to assess
patients’ mental disorders and psychiatric comorbidity according
to the DSM-IV classification system independently of their
diagnoses given by the neurologists (15). Interviews were
conducted on the same day after the neurological assessment.
We used the DSM-IV classification system since data collection
was conducted before the DSM-5 (20) came out. Furthermore,
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the DSM-IV is still the current clinical “gold” standard and no
German translation of the SCID for DSM-5 exists yet. However,
because most DSM-IV somatoform disorders have been merged
into DSM-5 somatic symptom disorder (SSD) (20), we decided
not to evaluate the concordance of DSM-IV somatoform disorder
diagnoses from our evaluation. All interviewers underwent
intensive training, which included practice interviews with
patients that were not recruited for the study. Interrater reliability
was evaluated via interviews with a simulated patient; Kappa
was 0.94. Interviewers were required to attend a regular SCID
supervision led by a senior physician (CL).
Statistical Analysis
We conducted all analyses using SPSS (version 24). We used
descriptive statistics to describe the sample and to evaluate
prevalence rates of diagnoses. A sensitivity analysis comparing
study sample and dropout group was conducted with t-tests
and chi-square tests. To test for differences among neurologists’
psychiatric diagnoses vs. current SCID-I diagnoses, chi-square
tests were conducted. Furthermore, the agreement rate between
the diagnosis given by neurologists after clinical diagnostic work-
up and the SCID-I diagnosis was evaluated using Cohen’s Kappa
coefficient (K), which was computed as follows: [(po-pc)/(1-pc)],
i.e., po is the observed agreement rate and pc the agreement rate
by chance. Cohen’s Kappa can be classified as follows: K≤ 0.20 no
or weak agreement; 0.21≤K≤ 0.40 small agreement; 0.41≤K≤
0.60 moderate agreement; 0.61 ≤ K ≤ 0.80 high agreement; 0.81
≤K≤ 1.00 very high agreement (21). In addition, we investigated
sensitivity and specificity of doctors’ assessments as indicators of
the true positive and true negative rates, respectively (22).
RESULTS
Sociodemographic and medical characteristics of the patient
study sample (n= 392) and the group excluded from the analyses
(n = 295) along with a sensitivity analysis regarding relevant
variables are presented in Table 1. Study sample and excluded
patients differed regarding age (with the study sample being
significantly younger). In the neurological diagnostic workup, a
total of 252 patients (64.3%) of the study sample were diagnosed
with a purely structural cause of vertigo. For the remaining
140 patients (35.7%), the vertigo and dizziness symptoms were
classified by the neurologists as having functional vertigo or
a functional component. About a third of patients received
more than one somatic diagnosis, thus 468 diagnoses were
given overall. Of those, 144 (30.8%) were functional vertigo and
dizziness, 324 (69.2%) included a structural dysfunction amongst
the main diagnoses.
Prevalence and Agreement of Psychiatric
Diagnoses: Neurologists’ Diagnoses
Compared to SCID-I
Table 2 presents the psychiatric diagnoses given by neurologists
and those after DSM-IV and their prevalence rates. Structured
clinical interview led to a total of 275 diagnoses and at least one
psychiatric diagnosis after DSM-IV in 174 (44.4%) of all patients;
TABLE 1 | Sociodemographic and medical characteristics of the study sample
and patients excluded from the analyses.
Study
sample
(n = 392)
Excluded from
analyses
(n = 295)
X2 or T
n (existing
data)
M (SD) or
n (%)
VARIABLE
Age, M (SD) 53.9 (15.8) 120 57.5 (16.9) T = 2.2*
Female gender, n (%) 221 (56.4) 295 180 (61.0) X2 = 1.5
Marital status (n % married) 246 (62.8) 119 74 (62.2) X2 = 8.2
Education 120 X2 = 1.4
9th grade or less, n (%) 161 (41.1) 50 (41.7)
10th grade, n (%) 124 (31.6) 36 (30.0)
High school graduate,
n (%)
45 (11.5) 14 (11.7)
University graduate,
n (%)
62 (15.8) 20 (16.7)
Neurological diagnoses, n
(total)
468 295 367
Functional vertigo and
dizziness symptoms, n
(%)
144 (30.8) 119 (32.4) X2 = 0.9
Vestibular paroxysmia,
n (%)
30 (6.4) 20 (5.4) X2 = 0.19
Vestibular migraine,
n (%)
75 (16.0) 41 (11.2) X2 = 3.3
Multisensory deficit,
n (%)
23 (4.9) 27 (7.4) X2 = 2.7
Benign paroxysmal
positional vertigo, n (%)
66 (14.1) 45 (12.3) X2 = 0.31
Central vertigo, n (%) 24 (5.1) 25 (6.8) X2 = 1.4
Meniere’s disease, n (%) 57 (12.2) 44 (12.0) X2 = 0.02
Vestibular neuritis, n (%) 22 (4.7) 12 (3.3) X2 = 0.85
Bilateral Vestibulopathy,
n (%)
27 (5.8) 34 (9.3) X2 = 4.5*
PSYCHOPATHOLOGY
Depression (BDI-II), M (SD) 11.4 (8.2) 112 11.9 (9.1) T = 0.61
Anxiety (BAI), M (SD) 13.2 (9.4) 115 14.8 (10.6) T = 1.53
Somatization (PHQ-15), M
(SD)
9.8 (4.9) 116 9.7 (5.0) T = −0.22
Multiple psychiatric and neurologic diagnoses were allowed if indicated.
DSM, Diagnostic and Statistical Manual of Mental Disorders; PHQ, Patient Health
Questionnaire; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory. *p < 0.05.
66 (16.8%) patients of the total sample fulfilled DSM-IV-criteria
of a depressive disorder, 130 (33.2%) patients fulfilled the criteria
of at least one anxiety disorder. The neurologists’ assessment led
to substantially lower rates of psychiatric diagnoses: 49 diagnoses
were given in total, 40 (10.2%) of all patients were diagnosed
with at least one psychiatric diagnosis, 15 (3.8%) patients of
the whole sample with a depressive disorder and 24 (6.1%)
with at least one anxiety disorder. Remaining diagnoses were
substance-related and adjustment disorders. Agreement between
the neurologists’ diagnoses and structured clinical interviews was
low throughout, with Cohen’s κ values below 0.2. A total of 10
(15.2%) depressive and 20 (15.3%) of all anxiety disorders were
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TABLE 2 | Diagnoses according to neurologists and DSM-IV.
Diagnosis Neurologist
n (% of total)
DSM-IV
n (% of total)
Total number of psychiatric diagnoses 49 (100) 275 (100)
Depressive disorder 15 (30.6) 66 (23.9)
Anxiety disorder 27 (55.1) 169 (61.5)
Panic disorder 15 (30.6) 23 (8.4)
Panic disorder with agoraphobia 2 (4.1) 25 (9.1)
Agoraphobia without panic disorder 2 (4.1) 40 (14.6)
Social phobia 0 (0.0) 14 (5.1)
Specific phobia 1 (2.0) 48 (17.5)
OCD 0 (0.0) 0 (0.0)
PTSD 0 (0.0) 9 (3.3)
GAD 2 (4.1) 10 (3.5)
Not otherwise specified 5 (10.2) 0 (0.0)
Substance-related disorder 1 (2.0) 31 (11.3)
Eating disorder 0 (0.0) 9 (3.3)
Adjustment disorder 6 (12.3) 0 (0.0)
OCD, obsessive-compulsive disorder; PTSD, posttraumatic stress disorder; GAD,
generalized anxiety disorder.
TABLE 3 | Agreement between doctor’s rating of psychiatric disorders and
DSM-IV-classification of disorders (excluding somatoform disorders).
DSM-IV Doctor’s rating X² Cohen’s κ
No (n) Yes (n)
ANY PSYCHIATRIC DIAGNOSIS GIVEN
No (n) 210 8 22.9*** 0.16
Yes (n) 142 32
DEPRESSIVE DISORDER
No (n) 321 5 27.7*** 0.20
Yes (n) 56 10
ANY ANXIETY DISORDER
No (n) 258 4 29.0*** 0.17
Yes (n) 110 20
DSM, Diagnostic and Statistical Manual of Mental Disorders. ***p < 0.001.
correctly identified by neurologists (see Table 3). For depression,
sensitivity of doctors’ diagnoses was 15.2%, specificity was 98.5%.
Rates were similar for anxiety disorders, with a sensitivity index
of 15.4% and specificity of 98.5%.
DISCUSSION
We investigated neurologists’ awareness of psychiatric
comorbidities in patients with vertigo and dizziness symptoms
at their first examination at a tertiary care center specialized
in vertigo and balance disorders. Our main finding was that
the recognition of psychiatric disorders amongst neurologists
in routine clinical practice is very low with only about 10% of
all patients being diagnosed with a psychiatric disorder by the
neurologist vs. about 44% fulfilling DSM-IV criteria. Further,
only 15% of depressive and anxiety disorders were identified
correctly, i.e., in accordance with DSM-IV criteria, among all
patients. On one hand, corresponding specificity rates were
high, indicating that when the neurologists make a psychiatric
diagnosis, it mostly is correct. On the other hand, however,
doctors in our investigation had a tendency not to give or not
to document psychiatric diagnoses in a high number of cases as
depicted by the low sensitivity rates.
Our findings of low agreement between SCID-I and doctors’
ratings relate to previous studies in neurology (8, 9) and other
medical fields (10–12) as well as to meta-analytic findings
(23). Agreement rates also correspond to findings comparing
standardized and unstandardized methods concerning patients
with psychiatric disorders (24–28). Standardized interviews such
as the SCID-I are seen as the “gold standard” to diagnose
mental disorders (29). However, they are highly time as well as
cost consuming and thus may not be conducted as a routine
diagnostic interview in primary, secondary, or tertiary care. This
was also true for the primary routine diagnostics in the current
study.
It is important to note that the study was conducted in
routine clinical practice, i.e., neurologists were trained to screen
for relevant mental disorders, but not explicitly instructed to
regularly perform a related questionnaire. Thus, it may be
that neurologists were aware of mental psychopathology and
simply did not note their impression in the file, especially
when a structural dysfunction was found. Moreover, there
were structural barriers for the documentation of psychiatric
disorders in routine clinical practice. Aspects of psychopathology
may have been described in the doctor’s report but were not
captured by the current study since only actual diagnoses were
evaluated. Hence, although our results likely underestimate
the diagnostic competency of neurologists during their clinical
practice in a tertiary care center, an adequate testing for
psychiatric comorbidities and disorders is mandatory and must
be included in the diagnostic workflow. In this regard, one
has to differentiate between secondary and tertiary care. In
secondary care, one would likely assume that a neurologist is
practicing within the standards of neurological care even if
psychiatric diagnoses are missed in individual patients. In tertiary
care, however, the finding that mental health comorbidities
that affect 30–50% of patients are very often not detected is
concerning. As it is not realistic to perform detailed standardized
interviews for mental disorders by a psychiatrist or psychologist
in a routine setting, one solution to this issue could be
the implementation of a screening procedure by application
of a validated, standardized short questionnaire (e.g., Beck
Depression Inventory [BDI; (30)], Beck Anxiety Inventory [BAI;
(31)], Hospital Anxiety and Depression Scale [HADS; (32)] ,
Somatic Symptom Disorder-B Criteria Scale [SSD-12; (33)]).
This could help to improve the awareness of mental disorders
and the rate of early diagnosis and treatment. However, it goes
without saying that self-report screening questionnaires do not
lead to greater awareness of and better care for mental health
comorbidities without equally implementing changes in clinical
workflow in order to ensure that mental health symptoms are
adequately dealt with. In this regard, research in cardiovascular
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care has shown that screening for depression does not improve
outcome for heart failure patients (34, 35). Further, a review
on recommendations for depression screening in primary care
found that patients who undergo screening do not have better
outcomes (36) and authors of a meta-analytic study on screening
tools for depression in non-mental health settings recommend
only using these tools if appropriate organizational strategies and
modifications are available (37). Similar findings have been made
in oncology, where evidence suggests that a positive screening
for psychological distress often does not lead to appropriate
care, although a referral is mandatory for the screening to
be effective in improving patients’ psychological outcome (38).
A strategy to better deal with mental health comorbidities
in somatic care in general and neurological care specifically
could be collaborative care approaches. Clinical guidelines
for managing functional symptoms already recommend a
collaborative stepped care approach in which the primary care
physician coordinates treatment procedures (39). Collaborative
care concepts have been implemented and evaluated for
depression and somatoform disorders, results indicate that
they are superior to treatment as usual (13, 40). For patients
with somatoform and functional disorders, the evaluation of
a pre- and post-intervention in primary care indicated that
the investigated interdisciplinary network (The Network for
Somatoform and Functional Disorders, Sofu-Net) was feasible
and helped to improve doctor-patient communication about
psychosocial distress (14). These collaborative care approaches
have in common that they have their starting point in primary
care. Patients at our center are usually referred from primary to
secondary care, the latter then refers to our tertiary treatment.
In contrast, an example of a stepped collaborative care concept
for our patient group analogous to the Sofu-Net (14) could
look as follows. The patient would first visit the primary care
physician (PCP). Based on this visit, the PCP could decide to
refer to secondary care (e.g., a neurologist). After this, PCP and
secondary care physician would discuss the findings and could
then decide to (a) observe the symptoms over a defined period
of time or (b) refer the patient to our center. Patients could be
screened for mental health comorbidities at any of these stages,
but at the latest at our center. If the screening is positive, the
PCP should be informed and initiate appropriate treatment, i.e.,
next to somatic care, psychotherapeutic treatment should be
initiated. This would require a care network that enables the
PCP to refer patients to psychotherapy and be informed about
the progress of therapy. This concept could apply to patients
presenting with both chronic and acute symptoms and would
ensure that patients with chronic complaints are always screened
for mental comorbidity. Those with acute symptoms would likely
more rarely present at the tertiary center. If they do present, they
would also be screened for psychopathology which would help to
recognize the symptoms at an early stage and therefore simplify
access to treatment if necessary, even if the vertigo and dizziness
symptoms resolve after a relatively short period of time.
The advantage of the current study is that we examined a
large sample size and used multiple sources of information and
diagnostic assessment methods such as routine clinical work-
ups and standardized interviews for mental disorders. However,
there are some limitations: Our sample is representative for
a specialized tertiary care center but not for all patients with
vertigo and dizziness. Thus, a selection bias must be assumed
with respect to chronification and a higher rate of psychiatric
disorders.
In conclusion, our results show that neurologists’ awareness of
psychiatric disorders in routine clinical practice in a specialized
tertiary care center for vertigo and dizziness is low. This is
in accordance with previous studies in both similar as well as
different medical fields. However, particularly since psychiatric
disorders tend to take a chronic course if not recognized early
(6, 7), diagnosis of psychopathology should be given more
importance and appropriate concepts of care, such as stepped
collaborative care, should be implemented.
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